Serum N‐Glycome analysis reveals pancreatic cancer disease signatures

Autor: Gerda C. M. Vreeker, Randa G. Hanna‐Sawires, Yassene Mohammed, Marco R. Bladergroen, Simone Nicolardi, Viktoria Dotz, Jan Nouta, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van derBurgt, Manfred Wuhrer, Rob A. E. M. Tollenaar

Publikováno v: Cancer Medicine, Vol 9, Iss 22, Pp 8519-8529 (2020)

Abstract Background &Aims Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer type with loco‐regional spread that makes the tumor surgically unresectable. Novel diagnostic tools are needed to improve detection of PDAC and increase patie

Externí odkaz: https://doaj.org/article/1acb182db2b74c88aa8104a34bcf47bd

Circulating mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

Autor: Fleur van der Sijde, Zakia Azmani, Marc G. Besselink, Bert A. Bonsing, Jan Willem B. de Groot, Bas Groot Koerkamp, Brigitte C. M. Haberkorn, Marjolein Y. V. Homs, Wilfred F. J. van IJcken, Quisette P. Janssen, Martijn P. Lolkema, Saskia A. C. Luelmo, Leonie J. M. Mekenkamp, Dana A. M. Mustafa, Ron H. N. van Schaik, Johanna W. Wilmink, Eveline E. Vietsch, Casper H. J. van Eijck

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 13 (2021)

Background: Biomarkers predicting treatment response may be used to stratify pancreatic ductal adenocarcinoma (PDAC) patients for therapy. The aim of this study was to identify circulating tumor DNA (ctDNA) mutations that associate with tumor progres

Externí odkaz: https://doaj.org/article/56708d8cb614448a80bd2b337bdf4405

Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial)

Autor: Mustafa Suker, Joost J. Nuyttens, Ferry A.L.M. Eskens, Brigitte C.M. Haberkorn, Peter-Paul L.O. Coene, Erwin van der Harst, Bert A. Bonsing, Alexander L. Vahrmeijer, J.Sven D. Mieog, Rutger Jan Swijnenburg, Daphne Roos, B.Groot. Koerkamp, Casper H.J. van Eijck

Publikováno v: EClinicalMedicine, Vol 17, Iss , Pp - (2019)

Background: We conducted a multicentre phase II trial to investigate feasibility and antitumor activity of sequential FOLFIRINOX and Stereotactic Body Radiotherapy (SBRT) in patients with locally advanced pancreatic cancer (LAPC), (LAPC-1 trial). Met

Externí odkaz: https://doaj.org/article/a418d643cf42499e991cf16f2da3aa38

Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trial

Autor: Thijs de Rooij, Jony van Hilst, Jantien A. Vogel, Hjalmar C. van Santvoort, Marieke T. de Boer, Djamila Boerma, Peter B. van den Boezem, Bert A. Bonsing, Koop Bosscha, Peter-Paul Coene, Freek Daams, Ronald M. van Dam, Marcel G. Dijkgraaf, Casper H. van Eijck, Sebastiaan Festen, Michael F. Gerhards, Bas Groot Koerkamp, Jeroen Hagendoorn, Erwin van der Harst, Ignace H. de Hingh, Cees H. Dejong, Geert Kazemier, Joost Klaase, Ruben H. de Kleine, Cornelis J. van Laarhoven, Daan J. Lips, Misha D. Luyer, I. Quintus Molenaar, Vincent B. Nieuwenhuijs, Gijs A. Patijn, Daphne Roos, Joris J. Scheepers, George P. van der Schelling, Pascal Steenvoorde, Rutger-Jan Swijnenburg, Jan H. Wijsman, Moh’d Abu Hilal, Olivier R. Busch, Marc G. Besselink, for the Dutch Pancreatic Cancer Group

Publikováno v: Trials, Vol 18, Iss 1, Pp 1-10 (2017)

Abstract Background Observational cohort studies have suggested that minimally invasive distal pancreatectomy (MIDP) is associated with better short-term outcomes compared with open distal pancreatectomy (ODP), such as less intraoperative blood loss,

Externí odkaz: https://doaj.org/article/48126af9caf94e8aa02a77e625589467

Nationwide validation of the ISGPS risk classification for postoperative pancreatic fistula after pancreatoduodenectomy

Autor: J. Annelie Suurmeijer, Anouk M. Emmen, Bert A. Bonsing, Olivier R. Busch, Freek Daams, Casper H. van Eijck, Susan van Dieren, Ignace H. de Hingh, Tara M. Mackay, J. Sven Mieog, I. Quintus Molenaar, Martijn W. Stommel, Vincent E. de Meijer, Hjalmar C. van Santvoort, Bas Groot Koerkamp, Marc G. Besselink

Publikováno v: Surgery, 173, 1248-1253
Dutch Pancreatic Cancer Group 2023, ' Nationwide validation of the ISGPS risk classification for postoperative pancreatic fistula after pancreatoduodenectomy : “Less is more” ', Surgery (United States), vol. 173, no. 5, pp. 1248-1253 . https://doi.org/10.1016/j.surg.2023.01.004
Surgery, 173, 5, pp. 1248-1253

Contains fulltext : 291891.pdf (Publisher’s version ) (Closed access) BACKGROUND: The International Study Group of Pancreatic Surgery 4-tier (ie, A-D) risk classification for postoperative pancreatic fistula grade B/C is based on pancreatic texture

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7605823f7529d868917228f0820a44f0
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150444860&origin=inward